Evidence-Based Hematologic Malignancy: Therapeutic Advances

A session at Evidence-Based Hematologic Malignancy: Therapeutic Advances

Saturday 8th April, 2017

8:00am to 5:00pm (EST)

The topics covered will include leukemia, myeloma, multiple myeloma, bone marrow transplant, toxicity, lymphoma, and challenging cases in hematologic malignancies. There will be a unique opportunity for discussion with world-renowned cancer specialists.

Upon conclusion of this program, participants should be able to:
Define the major indications for therapy for each hematologic malignancy.
Describe the appropriate molecular basis for therapy of hematologic malignancies.
Demonstrate awareness of the common toxicities with these novel therapies
Select the best approach to optimize management of these toxicities
Attendance at this Mayo course does not indicate nor guarantee competence or proficiency in the performance of any procedures which may be discussed or taught in this course.

Exhibit Opportunity
This course offers the unique opportunity for commercial companies to interact with health care providers and highlight their products and services. If you are interested in exhibiting at this course, please complete the attached exhibit forms and submit to FLACMEEXHIBITS@mayo.edu.

Brochure: https://go.evvnt.com/79865-1

Registration: USD 175

Sign in to add slides, notes or videos to this session

Tell your friends!


Time 8:00am5:00pm EST

Date Sat 8th April 2017

Short URL


Official session page


View the schedule


See something wrong?

Report an issue with this session